Draft:WuXi Biologics

Nov 22, 2018

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai

Nov 16, 2018

WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou

Nov 07, 2018

WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting

Oct 31, 2018

WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang

Oct 23, 2018

CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics

Oct 18, 2018

Samsung BioLogics named a Fortune Future 50 company

Sep 26, 2018

I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs

Sep 24, 2018

WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board